Trump’s Medicaid drug-price pledge faces a gap between sweeping claims and measurable savings
The administration says every state has joined a most-favored-nation Medicaid drug-pricing model that could deliver historic savings, while the available coverage largely repeats official projections rather than independently testing them.
a day ago







